National Center for Research Resources (NCRR): Sclerosis trials

The registry lists 10 Sclerosis studies with National Center for Research Resources (NCRR) as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 5Phase 3 2No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple SclerosisCompletedNCT00043264Phase 2
• Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic SclerosisStatus unknownNCT00006393
• Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple SclerosisStatus unknownNCT00006060
• Clinical Trial of Creatine in Amyotrophic Lateral SclerosisCompletedNCT00005766Phase 2
• Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS]CompletedNCT00005674Phase 2
• A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple SclerosisCompletedNCT00004816Phase 1
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple SclerosisCompletedNCT00004814Phase 3
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT00004786Phase 3
• Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron DiseaseCompletedNCT00004771Phase 2
• Phase II Study of Recombinant Relaxin for Progressive Systemic SclerosisCompletedNCT00004380Phase 2